Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jarius

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Journal of Neuroinflammation|March 21, 2018
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literatureS Jarius, K Ruprecht, J P Stellmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2017
A population-based prospective study of optic neuritisK Soelberg, S Jarius, Hpb Skejoe, et al.
Journal of Neurology|April 12, 2024
Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity-a potential diagnostic pitfall in patients with MOG-EM/MOGADS Jarius, M Ringelstein, K Schanda, et al.
Der Nervenarzt|September 29, 2018
[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]S Jarius, F Paul, O Aktas, et al.
Journal of Neuroinflammation|May 5, 2018
MOG encephalomyelitis: international recommendations on diagnosis and antibody testingS Jarius, F Paul, O Aktas, et al.
Journal of Neuroinflammation|June 25, 2017
Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosisS Hahn, G Trendelenburg, M Scharf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2013
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onsetN Collongues, R Marignier, A Jacob, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
Neurology|May 4, 2012
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patientsM I Leite, E Coutinho, M Lana-Peixoto, et al.
Journal of Neurology|July 6, 2020
Treatment of MOG antibody associated disorders: results of an international surveyD H Whittam, V Karthikeayan, E Gibbons, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Neuroinflammation|March 21, 2018
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literatureS Jarius, K Ruprecht, J P Stellmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2017
A population-based prospective study of optic neuritisK Soelberg, S Jarius, Hpb Skejoe, et al.
Journal of Neurology|April 12, 2024
Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity-a potential diagnostic pitfall in patients with MOG-EM/MOGADS Jarius, M Ringelstein, K Schanda, et al.
Der Nervenarzt|September 29, 2018
[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]S Jarius, F Paul, O Aktas, et al.
Journal of Neuroinflammation|May 5, 2018
MOG encephalomyelitis: international recommendations on diagnosis and antibody testingS Jarius, F Paul, O Aktas, et al.
Journal of Neuroinflammation|June 25, 2017
Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosisS Hahn, G Trendelenburg, M Scharf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2013
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onsetN Collongues, R Marignier, A Jacob, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapyA Harrer, H Tumani, S Niendorf, et al.
Neurology|May 4, 2012
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patientsM I Leite, E Coutinho, M Lana-Peixoto, et al.
Journal of Neurology|July 6, 2020
Treatment of MOG antibody associated disorders: results of an international surveyD H Whittam, V Karthikeayan, E Gibbons, et al.
Pageof 8